A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer’s Disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer’s Disease ; volume:9 ; number:1 ; day:8 ; month:7 ; year:2019 ; pages:1-14 ; date:12.2019
Scientific reports ; 9, Heft 1 (8.7.2019), 1-14, 12.2019
- Urheber
-
Gibbs, Ebrima
Silverman, Judith M.
Zhao, Beibei
Peng, Xubiao
Wang, Jing
Wellington, Cheryl L.
Mackenzie, Ian R.
Plotkin, Steven S.
Kaplan, Johanne M.
Cashman, Neil R.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-019-46306-5
- URN
-
urn:nbn:de:101:1-2019103106020950556615
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gibbs, Ebrima
- Silverman, Judith M.
- Zhao, Beibei
- Peng, Xubiao
- Wang, Jing
- Wellington, Cheryl L.
- Mackenzie, Ian R.
- Plotkin, Steven S.
- Kaplan, Johanne M.
- Cashman, Neil R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Specific detection of tau seeding activity in Alzheimer’s disease using rationally designed biosensor cells
Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
Prion protein oligomers cause neuronal cytoskeletal damage in rapidly progressive Alzheimer’s disease
Aβ oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer’s disease
Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples
Pharmacokinetic properties of D-peptides designed for treatment of Alzheimer’s disease
Rationally designed DNA origami hosts for protein guests
Rationally Designed Peptoid Inhibitors of Amyloid‐β Oligomerization
Characterization of high-density prion protein oligomers in rapid progressive and sporadic Alzheimer’s disease
A single-domain antibody detects and neutralises toxic Aβ42 oligomers in the Alzheimer’s disease CSF
Specific detection of tau seeding activity in Alzheimer’s disease using rationally designed biosensor cells
Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
Prion protein oligomers cause neuronal cytoskeletal damage in rapidly progressive Alzheimer’s disease
Aβ oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer’s disease
Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples
Pharmacokinetic properties of D-peptides designed for treatment of Alzheimer’s disease
Rationally designed DNA origami hosts for protein guests
Rationally Designed Peptoid Inhibitors of Amyloid‐β Oligomerization
Characterization of high-density prion protein oligomers in rapid progressive and sporadic Alzheimer’s disease
A single-domain antibody detects and neutralises toxic Aβ42 oligomers in the Alzheimer’s disease CSF
Specific detection of tau seeding activity in Alzheimer’s disease using rationally designed biosensor cells
Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
Prion protein oligomers cause neuronal cytoskeletal damage in rapidly progressive Alzheimer’s disease
Aβ oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer’s disease
Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples
Pharmacokinetic properties of D-peptides designed for treatment of Alzheimer’s disease
Rationally designed DNA origami hosts for protein guests
Rationally Designed Peptoid Inhibitors of Amyloid‐β Oligomerization
Characterization of high-density prion protein oligomers in rapid progressive and sporadic Alzheimer’s disease